Buscar
Mostrando ítems 1-6 de 6
Non-viable immunobiotic Lactobacillus rhamnosus CRL1505 and its peptidoglycan improve systemic and respiratory innate immune response during recovery of immunocompromised-malnourished mice
(Elsevier Science, 2015-03-02)
The effect of non-viable Lactobacillus rhamnosus CRL1505 and its cell wall and peptidoglycan on respiratory immunity in malnourished mice was studied.Weaned mice were malnourished with a protein-free diet for 21d and ...
Lactobacillus rhamnosus postbiotic-induced immunomodulation as safer alternative to the use of live bacteria
(Academic Press Ltd - Elsevier Science Ltd, 2021-10)
Many attempts have been made to search for safer immunomodulatory agents that enhance the immune response and reduce the number and severity of infections in at-risk populations. The use of postbiotics, non-viable microbial ...
Impacto de Lactobacillus rhamnosus CRL1505 sobre los mecanismos hemostáticos alterados durante la inmunosupresión experimental inducida por la ciclofosfamida
(Ediciones Médicas del Sur SRL, 2019)
Different drugs used during cancer treatments can affect the hemostatic mechanisms. Previously, we demonstrated that lactic acid bacteria modulate effectively coagulation activation during respiratory infections. The aim ...
Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation–coagulation interactions and reduces influenza virus-associated pulmonary damage
(Birkhauser Verlag Ag, 2015-08)
Objective: To evaluate the effect of the nasal administration of live and heat-killed Lactobacillus rhamnosus CRL1505 (Lr1505) on immune-coagulative response during influenza virus (IFV) infection to improve survival and ...
Improvement of myelopoiesis in cyclophosphamide-immunosuppressed mice by oral administration of viable or non-viable lactobacillus strains
(Frontiers Media S.A., 2021-04-12)
Myelosuppression is the major dose-limiting toxicity of cancer chemotherapy. There have been many attempts to find new strategies that reduce myelosuppression. The dietary supplementation with lactic acid bacteria (LAB) ...
Peptidoglycan from immunobiotic lactobacillus rhamnosus improves resistance of infant Mice to respiratory syncytial viral infection and secondary pneumococcal pneumonia
(Frontiers Research Foundation, 2017-08-10)
Several research works have demonstrated that beneficial microbes with the capacity to modulate the mucosal immune system (immunobiotics) are an interesting alternative to improve the outcome of bacterial and viral respiratory ...